Patheon to Provide Long-term Services to Aventis

On December 31, 2002, Patheon Inc. completed its agreement with Aventis Pharmaceuticals Inc. to provide long-term manufacturing and supply services to Aventis and to purchase Aventis’s pharmaceutical manufacturing and development site in Cincinnati, Ohio. Based in Mississauga, Ontario, Patheon is a leading independent provider of drug development and manufacturing services in pharmaceutical outsourcing. This is Patheon’s first site acquisition in the U.S. As part of the transaction, Patheon will also take over Aventis’s responsibilities under existing service contracts with a number of third-party pharmaceutical companies. The purchase price for the facility and related inventory was approximately US$30 million.

Patheon’s legal team was led by Riccardo Trecroce, general counsel and senior vice-president, corporate administration; Linda Beairsto, director, legal services; and Jill Leonard, legal counsel; assisted by Davies Ward Phillips & Vineberg LLP in Toronto and New York and Thompson Hine LLP in Cincinnati. The Davies team included Cameron Rusaw, Jennifer Toone, Rosemary Newman, Ryan Voegeli and Andrey Anishchenko (corporate) and John Ulmer and Joshua Wanderer (tax). The Thompson Hine team included Louis Solimine (corporate), Stephen King (real estate), Jane Garfinkel (regulatory), Andrew Kolesar (environmental) and Timothy Brown and Deborah Brenneman (pension/employment).

Aventis’s legal team was led by in-house counsel Sheila Wohl Chandonnet and Jessica Steinhart; assisted by Randall Pratt of Pratt & Pratt LLP, and Sandra Nunn and Christopher Habel of Frost Brown Todd LLC in Cinncinnati.